6.05
前日終値:
$6.33
開ける:
$6.32
24時間の取引高:
1.08M
Relative Volume:
0.89
時価総額:
$328.39M
収益:
$1.02B
当期純損益:
$-757.20M
株価収益率:
-0.4099
EPS:
-14.76
ネットキャッシュフロー:
$-257.90M
1週間 パフォーマンス:
-6.35%
1か月 パフォーマンス:
+22.22%
6か月 パフォーマンス:
-33.88%
1年 パフォーマンス:
-9.30%
Emergent Biosolutions Inc Stock (EBS) Company Profile
名前
Emergent Biosolutions Inc
セクター
電話
240-631-3200
住所
300 PROFESSIONAL DR, GAITHERSBURG, MD
EBS を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
EBS
Emergent Biosolutions Inc
|
6.05 | 350.63M | 1.02B | -757.20M | -257.90M | -14.76 |
![]()
HLN
Haleon Plc Adr
|
11.12 | 50.98B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
ZTS
Zoetis Inc
|
168.61 | 74.41B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
RDHL
Redhill Biopharma Ltd Adr
|
1.93 | 4.03M | 35.75M | 11.57M | -26.25M | -3.8069 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.99 | 46.23B | 30.08B | 710.16M | 4.45B | 0.2182 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.25 | 20.10B | 16.54B | -1.64B | 749.00M | -1.45 |
Emergent Biosolutions Inc Stock (EBS) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-12-30 | 開始されました | H.C. Wainwright | Buy |
2024-08-22 | 開始されました | Rodman & Renshaw | Buy |
2024-03-07 | アップグレード | The Benchmark Company | Hold → Buy |
2023-11-20 | 再開されました | JP Morgan | Underweight |
2023-08-29 | ダウングレード | The Benchmark Company | Buy → Hold |
2023-04-10 | アップグレード | The Benchmark Company | Hold → Buy |
2023-03-17 | ダウングレード | JP Morgan | Neutral → Underweight |
2022-11-10 | ダウングレード | The Benchmark Company | Buy → Hold |
2022-04-29 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
2022-01-20 | アップグレード | The Benchmark Company | Hold → Buy |
2021-11-08 | ダウングレード | The Benchmark Company | Buy → Hold |
2021-05-05 | ダウングレード | Argus | Buy → Hold |
2021-04-07 | 開始されました | The Benchmark Company | Buy |
2021-02-24 | アップグレード | Chardan Capital Markets | Neutral → Buy |
2021-02-19 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
2021-01-08 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
2020-09-14 | 再開されました | JP Morgan | Neutral |
2020-07-31 | 繰り返されました | Chardan Capital Markets | Buy |
2019-09-12 | 開始されました | Guggenheim | Buy |
2019-09-04 | アップグレード | Wells Fargo | Market Perform → Outperform |
2018-11-02 | アップグレード | Goldman | Neutral → Buy |
2018-08-03 | 繰り返されました | Chardan Capital Markets | Buy |
2018-06-13 | 開始されました | Argus | Buy |
2018-04-25 | ダウングレード | Wells Fargo | Outperform → Market Perform |
2018-01-24 | 開始されました | Goldman | Neutral |
2018-01-16 | 繰り返されました | Chardan Capital Markets | Buy |
2016-06-28 | 繰り返されました | Singular Research | Buy |
2016-04-15 | 開始されました | Chardan Capital Markets | Buy |
2016-03-28 | 開始されました | Singular Research | Buy |
2016-02-19 | 開始されました | Wells Fargo | Outperform |
2014-05-15 | 開始されました | Summer Street Research | Buy |
2011-05-31 | 繰り返されました | WBB Securities | Strong Buy |
2011-01-10 | 繰り返されました | Wedbush | Outperform |
2010-11-05 | 繰り返されました | Wedbush | Outperform |
2010-08-18 | アップグレード | WBB Securities | Buy → Strong Buy |
2010-08-06 | 繰り返されました | Caris & Company | Buy |
すべてを表示
Emergent Biosolutions Inc (EBS) 最新ニュース
Emergent BioSolutions at Jefferies Conference: Strategic Transformation By Investing.com - Investing.com Canada
Emergent BioSolutions (EBS) Partners with Foundation for Opioid Awareness | EBS Stock News - GuruFocus
Emergent BioSolutions Supports Victoria's Voice Foundation's Nat - GuruFocus
Breaking: Dramatic 34% Drop in US Opioid Deaths as Emergent Expands Life-Saving Naloxone Access - Stock Titan
Vaccine Contract Manufacturing Market Set to Witness - openPR.com
Biodefense Market Set to Witness Significant GrowthEmergent BioSolutions Inc., SIGA Technologies - openPR.com
Bank of America Corp DE Boosts Stake in Emergent BioSolutions Inc. (NYSE:EBS) - Defense World
Investors Can Still File Late Claims in Emergent BioSolutions Settlement - TradingView
Northern Trust Corp Acquires 3,692 Shares of Emergent BioSolutions Inc. (NYSE:EBS) - Defense World
Emergent BioSolutions discloses CEO stock purchase - MSN
Emergent Biosolutions Settlement Receives Preliminary Approval - TipRanks
Emergent BioSolutions ($EBS) Is Paying a $40M Settlement to Investors — Here’s How to Get Your Share - TradingView
Zacks.com featured highlights include BrightSpring Health Services, Beyond, Air Canada, HF Sinclair and Emergent BioSolutions - Yahoo Finance
Q1 EPS Forecast for Emergent BioSolutions Lowered by Analyst - Defense World
Emergent BioSolutions (EBS) Shares Surge 9.7% Following Positive Developments | EBS Stock News - GuruFocus
Emergent BioSolutions (EBS) CEO Increases Stake with $350,000 Sh - GuruFocus
Emergent BioSolutions (EBS) Shares Surge Over 13% | EBS Stock Ne - GuruFocus
Emergent BioSolutions (EBS) Shares Surge Over 14% | EBS Stock Ne - GuruFocus
Emergent BioSolutions (EBS) Shares Surge Over 14% | EBS Stock News - GuruFocus
Emergent BioSolutions (EBS) Shares Surge Over 13% | EBS Stock News - GuruFocus
Emergent BioSolutions stock up on insider purchase (EBS:NYSE) - Seeking Alpha
Insider Buying: Joseph Papa Acquires 60,000 Shares of Emergent B - GuruFocus
Insider Buying: Joseph Papa Acquires 60,000 Shares of Emergent BioSolutions Inc (EBS) - GuruFocus
Emergent BioSolutions to Participate in Upcoming Investor Conferences | EBS Stock News - GuruFocus
Emergent BioSolutions to Participate in Upcoming Investor Conferences - The Manila Times
Emergent BioSolutions Lines Up 4 Major Wall Street Conferences: RBC, Goldman Sachs, Jefferies Featured - Stock Titan
Wells Fargo & Company MN Sells 11,665 Shares of Emergent BioSolutions Inc. (NYSE:EBS) - Defense World
Emergent BioSolutions Inc.'s (NYSE:EBS) Share Price Boosted 29% But Its Business Prospects Need A Lift Too - simplywall.st
Emergent BioSolutions (EBS) Q1 2025 Earnings Highlight Turnaroun - GuruFocus
Emergent Biosolutions Q1 2025 Earnings Preview - MSN
Emergent BioSolutions Inc. (NYSE:EBS) Q1 2025 Earnings Call Transcript - Insider Monkey
Emergent Biosolutions (EBS) Q1 Earnings Top Estimates - MSN
Emergent biosolutions reaffirms 2025 revenue guidance of $750M-$850M amid turnaround progress - MSN
Emergent Biosolutions: Q1 Earnings Snapshot - New Haven Register
Emergent BioSolutions Inc. SEC 10-Q Report - TradingView
Emergent BioSolutions Inc (EBS) Q1 2025 Earnings Call Highlights: Strong Net Income Growth Amid ... - Yahoo
Emergent BioSolutions Reports First Quarter 2025 Financial Results - The Manila Times
Emergent BioSolutions Inc (EBS) Q1 2025 Earnings Call Highlights: Strong Net Income Growth Amid Revenue Challenges - GuruFocus
Earnings call transcript: Emergent BioSolutions Q1 2025 sees 656% net income rise - Investing.com Nigeria
Emergent Biosolutions earnings beat by $0.22, revenue fell short of estimates - Investing.com
Emergent Biosolutions Q1 2025 slides: turnaround progress drives profitability By Investing.com - Investing.com India
Emergent BioSolutions Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Emergent BioSolutions (EBS) Updates 2025 Financial Forecast | EBS Stock News - GuruFocus
Emergent BioSolutions (EBS) Reports Strong Q1 Revenue | EBS Stoc - GuruFocus
Emergent BioSolutions Reports 656% Net Income Surge - TipRanks
Emergent Biosolutions Q1 2025 slides: turnaround progress drives profitability - Investing.com
Emergent Biosolutions Inc (EBS) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):